Market Tracker

03/29 4:48pm ET

Nektar Therapeutics (NASDAQ:NKTR)

24.20
Delayed Data
As of Mar 29
 +0.27 / +1.13%
Today’s Change
11.41
Today|||52-Week Range
24.88
+97.23%
Year-to-Date

Today’s Trading

Previous close23.93
Today’s open23.92
Day’s range23.91 - 24.88
Volume2,263,917
Average volume (3 months)1,612,788
Market cap$3.7B
Dividend yield--
Data as of 3:59pm ET, 03/29/2017

Growth & Valuation

Earnings growth (last year)-80.33%
Earnings growth (this year)-14.94%
Earnings growth (next 5 years)-7.38%
Revenue growth (last year)-28.32%
P/E ratioNM
Price/Sales10.35
Price/Book41.60

Competitors

 Today’s
change
Today’s
% change
BLUEbluebird bio Inc-0.10-0.11%
TECHBio-Techne Corp-0.05-0.05%
NBIXNeurocrine Bioscienc...+1.29+3.10%
KITEKite Pharma Inc-0.10-0.13%
Data as of 3:59pm ET, 03/29/2017

Financials

Next reporting dateMay 3, 2017
EPS forecast (this quarter)-$0.39
Annual revenue (last year)$165.4M
Annual profit (last year)-$153.5M
Net profit margin-92.80%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Howard W. Robin
Chief Operating Officer &
Senior Vice President
John Nicholson
Corporate headquarters
San Francisco, California

Forecasts